Key facts
- Prantae Solutions’s last known valuation is $2.1M (Jan 2025).
- It has raised $580K; the latest was Seed Round ($580K) in Jan 2025.
- Notable investors include Indian Angel Network, Centre for Cellular And Molecular Platforms, Deepank Kumar, Nitin Zamre, Samir Kalia.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Prantae Solutions
- ·The full record, as it builds
Funding rounds
No funding rounds for Prantae Solutions are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Prantae Solutions
Operator of a health-connected ecosystem intended to enable self-health monitoring through low-power, portable IoT devices, and a diagnostic system for accurately measuring albumin and creatinine levels. The company platform offers user-friendly devices and specialized reagents, a combination of advanced optical sensing, high-definition imaging, and AI-driven algorithms, accessible and precise diagnostics, improving health monitoring and decision-making, enabling individuals and healthcare professionals to monitor health, assess kidney function, and gain molecular-level insights.
- Sector
- Healthcare
- HQ
- Bhubaneswar, India
- Founded
- 2015
- Employees
- 15
- Website
- prantae.solutions/
- Ownership
- Privately Held (backing)
Prantae Solutions doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Prantae Solutions shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Prantae Solutions in its N-PORT filings yet. We sweep new filings monthly.